Why the study?
Does a specific serum BNP cut-off accurately diagnose heart failure and predict survival in patients with chronic kidney disease presenting with dyspnea?
Does a specific serum BNP cut-off accurately diagnose heart failure and predict survival in patients with chronic kidney disease presenting with dyspnea?
Answers are grounded in this paper and cite their sources.
In patients with chronic kidney disease presenting with dyspnea, a higher BNP cut-off (858.5 pg/mL) is required to accurately diagnose heart failure and predict mortality compared to patients with normal renal function.
BACKGROUND/AIMS: Brain natriuretic peptide (BNP) levels are known to be elevated in patients with chronic kidney disease (CKD) and normal heart function. Therefore, the present study was performed to examine the effectiveness of BNP level in diagnosing heart failure in patients with CKD and to determine its effects on survival rate and prognosis. METHODS: A total of 182 patients with CKD who visited the hospital due to dyspnea of NYHA class II were included in the study. BNP levels were measured and echocardiography was performed to divide the subjects into groups with and without heart failure. Their BNP levels, clinical courses, and survival rates were analyzed retrospectively. RESULTS: When BNP level was >/=858.5 pg/mL in CKD patients, heart failure could be diagnosed with sensitivity and specificity of 77% and 72%, respectively. Survival rate of the group with BNP levels of >/=858.8 pg/mL was significantly lower than that of the group with BNP level below this threshold (p=0.012) and multivariate analysis showed that BNP level, age, and sex affected survival rate in the group with BNP level >/=858.8 pg/mL. CONCLUSIONS: BNP levels of patients with CKD showed a positive correlation with creatinine levels, and the critical point of BNP level for diagnosis of heart failure was 858.5 pg/mL. As the survival rate in patients with BNP level above the critical point was significantly low, this level was a useful indicator for predicting their prognosis. Care should be taken in interpreting BNP level because patients with stage 5 CKD may show a high concentration of BNP without heart failure.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: